Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Apple Warning Offsets Next-Inspired Retail Gains

Thu, 03rd Jan 2019 12:01

LONDON (Alliance News) - Stocks in London traded lower at midday on Thursday as Apple's sales warning shook markets, heightening fears of economic slowdown in China and causing stocks reliant on the country's demand to suffer, such as miners and luxury fashion house Burberry. Despite Burberry's tumble, it was a broadly positive session for clothing retailers after an encouraging Christmas performance from high-street chain Next. The FTSE 100 was down 41.76 points, or 0.6%, at 6,692.47, while the FTSE 250 was 39.53 points lower, or 0.2%, at 17,547.17. The AIM All-Share was up 0.3% at 863.22.The Cboe UK 100 was down 0.5% at 11,358.68, while the Cboe UK 250 was flat at 15,685.40, and the Cboe UK Small Companies up 0.3% at 10,930.93.In mainland Europe, the CAC 40 in Paris and the DAX 30 in Frankfurt were both down 1.5%.Markets in the US are poised for a sharp fall when they reopen on Thursday, with the Dow Jones seen down 1.6%, the S&P 500 called 1.7% lower and the Nasdaq on course to drop a steep 2.7%. This comes after Nasdaq constituent Apple, after the New York close on Wednesday, uncharacteristically issued a sales warning amid weak trading conditions in China. California-based Apple now expects first-quarter revenue of about USD84 billion, down from its prior estimate of between USD89 billion to USD93 billion. Apple also now expects gross margin of about 38%, at the lower of a previously guided range of between 38% and 38.5%.Apple, describing the quarter as "challenging", said it did not expect the magnitude of the economic deceleration in emerging markets, particularly in China. The company said most of its revenue shortfall relative to guidance, and over 100% of year-over-year worldwide revenue decline, occurred in China across the iPhone, Mac and iPad products.Russ Mould, investment director at AJ Bell, said the update from Apple spooked investors. "The consumer electronics giant's struggles are tied in closely with market fears about trade wars and the health of the Chinese economy, with a weak revenue performance in the last three months of 2018 blamed on the Greater China region."Mould noted that London-listed miners and other companies heavily reliant on Chinese consumption were struggling on Thursday. Mining stocks BHP and Glencore were down 1.6% and 1.3%, respectively, while Burberry was the worst performer in the FTSE 100, sinking 4.7%. The trench coat maker's fall came despite an upbeat session for UK retailers after Next reported a steady performance over the festive trading period. Next, the first London-listed retailer to reveal its performance for the important festive trading period, said strong sales in the three weeks prior to Christmas, along with a good half-term holiday week at the end of October, made up for disappointing sales in November. For the period from October 28 to December 29, Next recorded full-price sales growth of 1.0% on the year-earlier period, with online sales rising 15% and retail sales declining 9.2%. Total full-price sales including interest income for the period grew 1.5% on the prior year, in line with the company's September guidance.Though sales were in line, lower margin products and increased online trading meant Next nudged its pretax profit outlook for the year ending late January lower to GBP723 million, down 0.6% from previous guidance of GBP727 million.Clothing, food and homewares retailer Marks & Spencer was up 1.6% at midday, as were shares in Associated British Foods, parent of low-cost fashion chain Primark.Elsewhere on the London Stock Exchange, Vectura shares rose 13% after the respiratory disease-focused pharmaceutical firm said it expects earnings for 2018 to be above market expectations, while revenue is set to be in line.Vectura expects adjusted earnings before interest, taxes, depreciation and amortisation above consensus expectations, due to margin improvements, productivity initiatives and overall revenue mix.Research and development investment for 2018 is expected in the range of GBP55 million to GBP65 million, while guidance for 2019 has been kept at GBP45 million to GBP55 million.In economic data on Thursday, figures showed the UK construction sector expanded at the slowest rate in three months at the end of 2018, though it remained in growth territory for the ninth consecutive month. The IHS Markit/CIPS Purchasing Managers' Index came in at 52.8 in December, down from 53.4 in November and slightly below consensus forecasts of 52.9. The score remained above the neutral mark of 50, which separates expansion from contraction. Markit said UK construction firms indicated a disappointing end to the year as business activity growth eased to a three-month low and new orders expanded at a relatively muted pace. The slowdown in construction growth mainly reflected softer rises in commercial and housing activity during December, said Markit. However, a bright spot was civil engineering activity, which rose at the fastest pace since May 2017.The pound was quoted at USD1.2561 at midday, down from USD1.2591 late Wednesday.To come in Thursday's economic calendar, private payroll processor ADP releases US employment change figures for November at 1315 GMT, a precursor to Friday's monthly nonfarm payrolls report.

More News
3 Oct 2019 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
26 Sep 2019 15:43

Vectura Senior Independent Non-Executive Foden Leaves, Werner Replaces

Vectura Senior Independent Non-Executive Foden Leaves, Werner Replaces

Read more
24 Sep 2019 12:56

Tuesday broker round up

(Sharecast News) - TUI: UBS upgrades to neutral with a target price of 900p.

Read more
11 Sep 2019 13:12

Wednesday broker round-up

(Sharecast News) - Renew Holdings: Peel Hunt initiates at buy with a target price of 500p.

Read more
11 Sep 2019 09:31

BROKER RATINGS SUMMARY: HSBC Downgrades Shell To Hold From Buy

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:----------FTSE 100----------HSBC CUTS ROYAL DUTCH SHELL TO - BP

Read more
10 Sep 2019 10:17

Vectura Proposes Capital Return Amid "Strong" Interim Revenue Growth

(Alliance News) - Drug development firm Vectura Group PLC proposed a special dividend and buyback Tuesday after reporting revenue jumped on a strong inhaler performance with losses the six months

Read more
3 Sep 2019 16:17

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 4 September Oxford BiomedicaHalf Year ResultsDunelm GroupFull Year Year Income

Read more
17 Jul 2019 10:16

Vectura Confirms Annual Outlook; Plans GBP50 Million Shareholder Award

(Alliance News) - Vectura Group PLC on Wednesday confirmed its research & development investment priorities and proposed a GBP50 million capital return.The pharmaceutical company said a

Read more
17 Jul 2019 08:35

LONDON MARKET OPEN: Fresnillo, Johnson Matthey Help Pull FTSE 100 Down

(Alliance News) - Stocks began the day lower in London on Wednesday, with Fresnillo and Johnson Matthey failing to please investors, though there were a number of

Read more
10 Jun 2019 09:13

Vectura Chief Executive To Leave; Finance Head Named As Interim CEO

LONDON (Alliance News) - Vectura Group PLC on Monday said Chief Executive James Ward-Lilley will be stepping down at the end of June.Paul Fry, chief financial officer, will assume the role

Read more
10 Jun 2019 07:41

LONDON MARKET PRE-OPEN: Vectura And MJ Gleeson CEOs Leave

LONDON (Alliance News) - Stock prices in London are seen opening higher on Monday after US President Donald Trump suspended his plans for tariffs on Mexico, while hopes of lower US interest rates

Read more
29 May 2019 14:41

Vectura trading in line, mulling capital returns

(Sharecast News) - Vectura confirmed on Wednesday that its outlook remains in line with guidance for the full year as it said it was considering returning some capital to shareholders.

Read more
29 May 2019 13:44

Wednesday broker round-up

(Sharecast News) - Serco: RBC Capital Markets upgrades to outperform with a target price of 150p.

Read more
29 May 2019 10:01

Vectura Group On Track, Confident On Prospects For Rest Of 2019

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC said at its annual general meeting Wednesday it is on track to meet full year guidance.In March, the firm reported a slightly

Read more
24 May 2019 09:35

Vectura Gets Milestone Payment On Novartis Submission Of Asthma Drug

LONDON (Alliance News) - Pharmaceutical company Vectura Group PLC said it is to receive a USD2.5 million milestone payment from Novartis AG relating to possible new asthma therapy filed a with EU

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.